GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » ARYA Sciences Acquisition Corp II (NAS:ARYBU) » Definitions » Quick Ratio

ARYA Sciences Acquisition II (ARYA Sciences Acquisition II) Quick Ratio : 4.02 (As of Jun. 2020)


View and export this data going back to 2020. Start your Free Trial

What is ARYA Sciences Acquisition II Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. ARYA Sciences Acquisition II's quick ratio for the quarter that ended in Jun. 2020 was 4.02.

ARYA Sciences Acquisition II has a quick ratio of 4.02. It generally indicates good short-term financial strength.

The historical rank and industry rank for ARYA Sciences Acquisition II's Quick Ratio or its related term are showing as below:

ARYBU' s Quick Ratio Range Over the Past 10 Years
Min: 4.02   Med: 4.02   Max: 4.02
Current: 4.02

During the past 0 years, ARYA Sciences Acquisition II's highest Quick Ratio was 4.02. The lowest was 4.02. And the median was 4.02.

ARYBU's Quick Ratio is not ranked
in the Diversified Financial Services industry.
Industry Median: 1.16 vs ARYBU: 4.02

ARYA Sciences Acquisition II Quick Ratio Historical Data

The historical data trend for ARYA Sciences Acquisition II's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ARYA Sciences Acquisition II Quick Ratio Chart

ARYA Sciences Acquisition II Annual Data
Trend
Quick Ratio

ARYA Sciences Acquisition II Semi-Annual Data
Feb20 Mar20 Jun20
Quick Ratio - 0.11 4.02

Competitive Comparison of ARYA Sciences Acquisition II's Quick Ratio

For the Shell Companies subindustry, ARYA Sciences Acquisition II's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ARYA Sciences Acquisition II's Quick Ratio Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, ARYA Sciences Acquisition II's Quick Ratio distribution charts can be found below:

* The bar in red indicates where ARYA Sciences Acquisition II's Quick Ratio falls into.



ARYA Sciences Acquisition II Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

ARYA Sciences Acquisition II's Quick Ratio for the fiscal year that ended in . 20 is calculated as

ARYA Sciences Acquisition II's Quick Ratio for the quarter that ended in Jun. 2020 is calculated as

Quick Ratio (Q: Jun. 2020 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(1.633-0)/0.406
=4.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ARYA Sciences Acquisition II  (NAS:ARYBU) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


ARYA Sciences Acquisition II Quick Ratio Related Terms

Thank you for viewing the detailed overview of ARYA Sciences Acquisition II's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ARYA Sciences Acquisition II (ARYA Sciences Acquisition II) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
51 Astor Place, 10th Floor, New York, NY, USA, 10003
Website
ARYA Sciences Acquisition Corp II is a blank check company.
Executives
Joseph Edelman director C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Advisors Llc director 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Life Sciences Master Fund Ltd director C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Adam Leo Stone director, officer: Chief Executive Officer C/O SOLID BIOSCIENCES, LLC, 141 PORTLAND STREET, FIFTH FLOOR, CAMBRIDGE MA 02139
Michael Seth Altman director, officer: Chief Financial Officer C/O PERCEPTIVE ADVISORS, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Arya Sciences Holdings Ii 10 percent owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Todd Wider director 4848 LEMMON AVENUE, SUITE 517, DALLAS TX 75219
Jake Bauer director C/O MYOKARDIA, INC., 333 ALLERTON AVENUE, SOUTH SAN FRANCISCO CA 94080
Konstantin Poukalov officer: Chief Business Officer C/O KADMON HOLDINGS, LLC, 450 E 29TH STREET, NEW YORK NY 10016
Chad M Robins director C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1551 EASTLAKE AVE E STE 200, SEATTLE WA 98102